Person who experienced the adverse event (patient)
| Event ID | CASE | I F COD | FOLL SEQ | IMAGE | EVENT DT | MFR DT | FDA DT | REPT COD | MFR NUM | MFR SNDR | AGE | AGE COD | GNDR COD | E SUB | WT | WT COD | REPT DT | OCCP COD | DEATH DT | TO MFR | CONFID | REPORTER COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 6809300 | 7436271 | F | 6809300-9 | 20100327 | 20100621 | 20100630 | EXP | CH-BRISTOL-MYERS SQUIBB COMPANY-15161813 | BRISTOL-MYERS SQUIBB COMPANY | 76 | YR | M | Y | 20100629 | OT | GERMANY |
Drug(s) used by person
| Event ID | DRUG SEQ | ROLE COD | DRUGNAME | VAL VBM | ROUTE | DOSE VBM | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 6809300 | 1014002669 | PS | GLUCOPHAGE | 1 | ORAL | 020357 | |||||
| 6809300 | 1014002670 | SS | LANTUS | 1 | SUBCUTANEOUS | DISCONTINUED ON 27MAR10 RE-INTRODUCED ON AN UNK DATE | |||||
| 6809300 | 1014002671 | SS | ACTOS | 1 | ORAL | ||||||
| 6809300 | 1014002672 | SS | AMARYL | 1 | ORAL | ||||||
| 6809300 | 1014002673 | C | ASPIRIN | 1 | |||||||
| 6809300 | 1014002674 | C | MEVALOTIN | 2 | ORAL | ||||||
| 6809300 | 1014002675 | C | DETRUSITOL | 2 | ORAL |
Indications of drugs used
| no results found |
Outcome of event
| Event ID | OUTC COD |
|---|---|
| 6809300 | HO |
Reactions reported
| Event ID | PT |
|---|---|
| 6809300 | HYPOGLYCAEMIA |
| 6809300 | SOMNOLENCE |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|
| 6809300 | 1014002669 | 20100327 | |||
| 6809300 | 1014002671 | 20100327 | |||
| 6809300 | 1014002672 | 20100327 |